The current standard of care for CTCL
In this video, Pierluigi Porcu, MD, Sidney Kimmel Cancer Center, Philadelphia, PA, outlines the current standard of care (SoC) for cutaneous T-cell lymphoma (CTCL). Dr Porcu explains that the therapeutic approach selected for a patient is based on the stage of the disease at presentation. Patients with early-stage disease typically receive various forms of skin-directed therapy, which can be effective for a long time. Advanced-stage disease and early-stage disease that stops responding to skin-directed therapies require systemic treatment. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
